From 20 October till 24 October 2023: HIGHLIGHTS FROM ESMO

Your direct line with Madrid

The European Society of Medical Oncology (ESMO) 2023 brings together leading experts in the different fields of cancer from around the world. And this year they gather together in Madrid, Spain. The MediMix team is also onsite, and will – together with your Belgian colleagues – keep you posted about the hottest topics as they happen. And, we dive into posters and hot topics with the experts as they are being presented.

Stay tuned, and get ready for an exciting and informative journey!

With the educational support of:

Presidential highlights

Daily highlights in breast cancer

Daily highlight in metastatic breast cancer

The latest findings from the Survival Update of the DESTINY-Breast04 trial were presented, focusing on the comparison between trastuzumab deruxtecan (T-DXd) treatment and physician’s choice treatment in HER2-low unresectable/metastatic breast

See video »

In-depth stories about breast cancer

The TULIP trial

The TULIP trial represents a pivotal phase 3 study conducted to assess the efficacy of trastuzumab duocarmazine (T-Duo) in patients suffering from metastatic breast cancer with HER2 overexpression. In this

See video »

The KEYNOTE-756 trial

In a discussion at ESMO between Dr Eline Naert, medical oncologist from Genth University Hospital and Prof Evandro De Azambuja from Institut Jules Bordet, the focus was on the

See video »

Breast cancer poster selection

EMBER-2 study: final results

Prof Patrick Neven, gynaecological oncologist at University Hospital Leuven, summarizes the poster he presented.

A preoperative window-of-opportunity (WOO) study of imlunestrant in ER+, HER- early breast cancer (EBC): Final analysis from

See video »

With the educational support of:

Z1. Researchpark 30, 1731 Zellik, Belgium
Website created by MediMix © 2023 - Privacy Policy